A Delaware health insurance company has filed a class action lawsuit against a number of generic metformin manufacturers due to the presence of NDMA; a known cancer-causing agent.…
A generic Regeneron recall warns that some bottles contain pills with twice the dose due to a labeling error.…
Aurobindo reports that the FDA has found more problems at its India production facilities during inspections last month in the wake of valsartan recalls.…
An FDA warning letter to generic valsartan drug manufacturer Aurobindo accuses the company of failures in oversight and quality assurance of its generic drug products.…
Aurobindo is recalling another 80 lots of valsartan and valsartan-combination blood pressure medications due to the presence of potentially cancer-causing impurities.…
